← Eichor
Condition: Schwannomatosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Schwannomatosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05684692
Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis
Phase 1/Phase 2 · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT04085159
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Phase 2 · 6 location(s) · Scott R. Plotkin, MD, PhD · NCT04374305
Neurofibromatosis (NF) Registry Portal
Phase N/A · 1 location(s) · The Children's Tumor Foundation · NCT01885767
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.